Transmitted HIV Drug Resistance — The Role of an Ultra-Sensitive Assay
In this prospective study, 20% of treatment-naive patients had minority drug-resistance mutations detected on an ultra-sensitive assay, but the presence of such mutations did not lead to worse outcomes.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)